Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
Clinical trial NCT04481932 · RECRUITING
Trial details
- NCT number
- NCT04481932
- Sponsor
- Peking University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2022-06-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.